Granules India Gets USFDA Nod for Generic Depression Drug
October 18, 2024 13:40
Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion Hydrochloride extended-release tablets USP (SR), expanding its presence in the US...